Synaptic plasticity, dopamine and Parkinson's disease: One step ahead

Brain

Volumn 132, Issue 2, 2009, Pages 285-287

  Calabresi, Paolo ^a,b   Mercuri, Nicola Biagio ^b,c   Di Filippo, Massimiliano ^a,b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; LEVODOPA; PHOSPHOPROTEIN DARPP 32;

BASAL GANGLION; BRAIN DEPTH STIMULATION; BRAIN REGION; DYSKINESIA; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; HUMAN; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MEMORY; MICROELECTRODE; NERVE CELL DEGENERATION; NERVE CELL PLASTICITY; NOTE; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANTIPARKINSON AGENTS; BASAL GANGLIA; DEEP BRAIN STIMULATION; DOPAMINE; HUMANS; LEVODOPA; NEURONAL PLASTICITY; PARKINSON DISEASE; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

EID: 60149088953     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn340     Document Type: Note

References (10)

1. Bezard E, Brotchie JM, Gross CE. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 2001; 2: 577-88.
2. Calabresi P, Maj R, Pisani A, Mercuri NB, Bernardi G. Long-term synaptic depression in the striatum: physiological and pharmacological characterization. J Neurosci 1992; 12: 4224-33.
3. Calabresi P, Picconi B, Parnetti L, Di Filippo M. A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine- acetylcholine synaptic balance. Lancet Neurol 2006; 5: 974-83.
4. Calabresi P, Picconi B, Tozzi A, Di Filippo M.. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 2007; 30: 211-9.
5. Di Filippo M, Picconi B, Tantucci M, Ghiglieri V, Bagetta V, Sgobio C, et al. Short-term and long-term plasticity at corticostriatal synapses: implications for learning and memory. Behav Brain Res 2008; October 2 (Epub ahead of print).
6. Goldberg MS, Pisani A, Haburcak M, Vortherms TA, Kitada T, Costa C, et al. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 2005; 45: 489-96.
7. Mercuri NB, Bernardi G. The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? Trends Pharmacol Sci 2005; 26: 341-4.
8. Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain 2006; 129: 1059-69.
9. Picconi B, Centonze D, Håkansson K, Bernardi G, Greengard P, Fisone G, et al. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 2003; 6: 501-6.
10. Prescott IA, Dostrovsky JO, Moro E, Hodaie M, Lozano AM, Hutchison WD. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkisnon's disease patients. Brain 2008; December 2 (Epub ahead of print).